ClinicalTrials.govpublic full text
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
pharmacokinetics of three pde5is, healthy subjects, genetic polymorphic cyp3a5, cyp3a5, sildenafil, udenafil, vardenafil, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908003
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.